UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study

Clinical trial NCT07163624 · COMPLETED

Trial details

NCT number: NCT07163624
Sponsor: The United Bio-Technology (Hengqin) Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2025-03-22
Primary completion: 2025-11-21
Enrollment: 211

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.